DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
14.30
-0.01 (-0.07%)
Aug 1, 2025, 4:00 PM - Market closed
United States Steel Revenue
DENTSPLY SIRONA had revenue of $879.00M in the quarter ending March 31, 2025, a decrease of -7.76%. This brings the company's revenue in the last twelve months to $3.72B, down -5.61% year-over-year. In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%.
Revenue (ttm)
$3.72B
Revenue Growth
-5.61%
P/S Ratio
0.77
Revenue / Employee
$265,643
Employees
14,000
Market Cap
2.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
| Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
| Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
| Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
| Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
XRAY News
- 12 days ago - Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer - GlobeNewsWire
- 19 days ago - Dental 3D Printing Market Forecast Study 2025, with Leading Dental Companies and Innovators BEGO, Dentsply Sirona, WhipMix, Straumann, Ivoclar, Formlabs, SprintRay, Asiga, and Shining3D - GlobeNewsWire
- 23 days ago - Dentsply Sirona to Host Second Quarter Conference Call on August 7th - GlobeNewsWire
- 6 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 6 weeks ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 weeks ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect - Accesswire
- 7 weeks ago - INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY - Accesswire